Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.

Improved mobilization of the CD34(+) and CD133(+) bone marrow-derived circulating progenitor cells by freshly isolated intracoronary bone marrow cell transplantation in patients with ischemic heart disease.

Turan RG, Bozdag-Turan I, Ortak J, Akin I, Kische S, Schneider H, Turan CH, Rehders TC, Rauchhaus M, Kleinfeldt T, Adolph E, Brehm M, Yokus S, Steiner S, Sahin K, Nienaber CA, Ince H.

Stem Cells Dev. 2011 Sep;20(9):1491-501. doi: 10.1089/scd.2010.0373. Epub 2010 Dec 29.

2.

The role of interdisciplinary team approach in the management of the diabetic foot: a joint statement from the Society for Vascular Surgery and the American Podiatric Medical Association.

Sumpio BE, Armstrong DG, Lavery LA, Andros G; SVS/APMA writing group.

J Vasc Surg. 2010 Jun;51(6):1504-6. doi: 10.1016/j.jvs.2010.04.010.

3.

Stem cell and progenitor cell therapy in peripheral artery disease. A critical appraisal.

Lawall H, Bramlage P, Amann B.

Thromb Haemost. 2010 Apr;103(4):696-709. doi: 10.1160/TH09-10-0688. Epub 2010 Feb 19. Review.

PMID:
20174766
4.

Intraoperative adjunctive stem cell treatment in patients with critical limb ischemia using a novel point-of-care device.

Kolvenbach R, Kreissig C, Cagiannos C, Afifi R, Schmaltz E.

Ann Vasc Surg. 2010 Apr;24(3):367-72. doi: 10.1016/j.avsg.2009.07.018. Epub 2009 Nov 6.

PMID:
19896796
5.

Long-term outcomes after medical and interventional therapy of critical limb ischemia.

Lawall H, Gorriahn H, Amendt K, Ranft J, Bramlage P, Diehm C.

Eur J Intern Med. 2009 Oct;20(6):616-21. doi: 10.1016/j.ejim.2009.06.002. Epub 2009 Jul 17.

PMID:
19782924
6.

Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature.

Fadini GP, Agostini C, Avogaro A.

Atherosclerosis. 2010 Mar;209(1):10-7. doi: 10.1016/j.atherosclerosis.2009.08.033. Epub 2009 Aug 21. Review.

PMID:
19740466
7.

History of foot ulcer increases mortality among individuals with diabetes: ten-year follow-up of the Nord-Trøndelag Health Study, Norway.

Iversen MM, Tell GS, Riise T, Hanestad BR, Østbye T, Graue M, Midthjell K.

Diabetes Care. 2009 Dec;32(12):2193-9. doi: 10.2337/dc09-0651. Epub 2009 Sep 3.

8.
9.

Autologous bone marrow stem cell transplantation in patients with end-stage chronical critical limb ischemia and diabetic foot.

Procházka V, Gumulec J, Chmelová J, Klement P, Klement GL, Jonszta T, Czerný D, Krajca J.

Vnitr Lek. 2009 Mar;55(3):173-8.

PMID:
19378841
10.

New techniques for endovascular treatment of peripheral artery disease with focus on chronic critical limb ischemia.

Zeller T, Sixt S, Rastan A.

Vasa. 2009 Feb;38(1):3-12. doi: 10.1024/0301-1526.38.1.3. Review.

PMID:
19229799
11.

Long-term prognosis of diabetic patients with critical limb ischemia: a population-based cohort study.

Faglia E, Clerici G, Clerissi J, Gabrielli L, Losa S, Mantero M, Caminiti M, Curci V, Quarantiello A, Lupattelli T, Morabito A.

Diabetes Care. 2009 May;32(5):822-7. doi: 10.2337/dc08-1223. Epub 2009 Feb 17. Erratum in: Diabetes Care. 2009 Jul;32(7):1355. Luppattelli, Tommaso [corrected to Lupattelli, Tommaso].

12.

Combined primary subintimal and endoluminal angioplasty for ischaemic inferior-limb ulcers in diabetic patients: 5-year practice in a multidisciplinary 'diabetic-foot' service.

Alexandrescu V, Hubermont G, Philips Y, Guillaumie B, Ngongang Ch, Coessens V, Vandenbossche P, Coulon M, Ledent G, Donnay JC.

Eur J Vasc Endovasc Surg. 2009 Apr;37(4):448-56. doi: 10.1016/j.ejvs.2008.12.005. Epub 2009 Feb 11.

13.

[Rheology and coronary heart disease].

Leschke M.

Dtsch Med Wochenschr. 2008 Dec;133 Suppl 8:S270-3. doi: 10.1055/s-0028-1100960. Epub 2008 Dec 15. Review. German.

PMID:
19085805
14.

Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia.

Matoba S, Tatsumi T, Murohara T, Imaizumi T, Katsuda Y, Ito M, Saito Y, Uemura S, Suzuki H, Fukumoto S, Yamamoto Y, Onodera R, Teramukai S, Fukushima M, Matsubara H; TACT Follow-up Study Investigators.

Am Heart J. 2008 Nov;156(5):1010-8. doi: 10.1016/j.ahj.2008.06.025. Epub 2008 Sep 19.

PMID:
19061721
15.
16.

Intermittent intravenous urokinase for critical limb ischemia in diabetic foot ulceration.

Weck M, Rietzsch H, Lawall H, Pichlmeier U, Bramlage P, Schellong S.

Thromb Haemost. 2008 Sep;100(3):475-82.

PMID:
18766265
17.

Heparin-induced Extracorporal LDL precipitation (H.E.L.P) in diabetic foot syndrome - preventive and regenerative potential?

Rietzsch H, Panzner I, Selisko T, Julius U, Jabs N, Reimann M, Bonifacio E, Bornhäuser M, Bornstein SR.

Horm Metab Res. 2008 Jul;40(7):487-90. doi: 10.1055/s-2008-1077071.

PMID:
18622889
18.

Intramuscular or combined intramuscular/intra-arterial administration of bone marrow mononuclear cells: a clinical trial in patients with advanced limb ischemia.

Van Tongeren RB, Hamming JF, Fibbe WE, Van Weel V, Frerichs SJ, Stiggelbout AM, Van Bockel JH, Lindeman JH.

J Cardiovasc Surg (Torino). 2008 Feb;49(1):51-8.

PMID:
18212687
19.

Current state of endovascular treatment of femoro-popliteal artery disease.

Zeller T.

Vasc Med. 2007 Aug;12(3):223-34. Review.

PMID:
17848483
20.

Transplantation of autologous mononuclear bone marrow stem cells in patients with peripheral arterial disease (the TAM-PAD study).

Bartsch T, Brehm M, Zeus T, Kögler G, Wernet P, Strauer BE.

Clin Res Cardiol. 2007 Dec;96(12):891-9. Epub 2007 Aug 17.

PMID:
17694378

Supplemental Content

Support Center